ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC36697-10mg |
|
1355631-24-1 |
Nav1.7 inhibitor
|
0 | C15H11Cl3FNO4S | |
GC36697-5mg |
|
1355631-24-1 |
Nav1.7 inhibitor
|
0 | C15H11Cl3FNO4S | |
GC36697-2mg |
|
1355631-24-1 |
Nav1.7 inhibitor
|
0 | C15H11Cl3FNO4S | |
GC36697-10mM (in 1mL DMSO) |
|
1355631-24-1 |
Nav1.7 inhibitor
|
0 | C15H11Cl3FNO4S | |
GC36696-5g |
|
18916-17-1 |
Naringin Dihydrochalcone
|
0 | C27H34O14 | |
GC36696-1g |
|
18916-17-1 |
Naringin Dihydrochalcone
|
0 | C27H34O14 | |
GC36696-500mg |
|
18916-17-1 |
Naringin Dihydrochalcone
|
0 | C27H34O14 | |
GC36696-100mg |
|
18916-17-1 |
Naringin Dihydrochalcone
|
0 | C27H34O14 | |
GC36696-10mM (in 1mL DMSO) |
|
18916-17-1 |
Naringin Dihydrochalcone
|
0 | C27H34O14 | |
GC36695-5mg |
|
38302-15-7 |
Naringenin trimethyl ether
|
0 | C18H18O5 | |
GC36694-5mg |
|
3682-04-0 |
Naringenin triacetate
|
0 | C21H18O8 | |
GC36693-10mg |
|
1190021-64-7 |
Naratriptan D3 Hydrochloride
|
0 | C17H23D3ClN3O2S | |
GC36693-5mg |
|
1190021-64-7 |
Naratriptan D3 Hydrochloride
|
0 | C17H23D3ClN3O2S | |
GC36693-1mg |
|
1190021-64-7 |
Naratriptan D3 Hydrochloride
|
0 | C17H23D3ClN3O2S | |
GC36691-10mg |
|
1256448-47-1 |
Nanatinostat
|
0 | C20H19FN6O2 | |
GC36691-10mM (in 1mL DMSO) |
|
1256448-47-1 |
Nanatinostat
|
0 | C20H19FN6O2 | |
GC36691-5mg |
|
1256448-47-1 |
Nanatinostat
|
0 | C20H19FN6O2 | |
GC36691-25mg |
|
1256448-47-1 |
Nanatinostat
|
0 | C20H19FN6O2 | |
GC36691-100mg |
|
1256448-47-1 |
Nanatinostat
|
0 | C20H19FN6O2 | |
GC36691-50mg |
|
1256448-47-1 |
Nanatinostat
|
0 | C20H19FN6O2 | |